Table 3.

Countries productive of schizophrenia trials ordered by level of productivity

country	GDP (mUS $)	actual trials > 100	predicted trials	% predicted output (95% confidence intervals)
Finland	119834	38	2	1900 (1312–2488)
South Africa	129094	26	5	520 (340–700)
Denmark	161455	79	12	658 (525–792)
Canada	607702	275	118	233 (212–254)
Norway	153362	24	10	240 (167–313)
Greece	118172	15	2	750 (397–1103)
Switzerland	172400	54	15	360 (278–442)
Sweden	227757	101	28	361 (301–421)
Poland	135623	17	6	283 (175–392)
UK	1283335	669	279	240(226–254)
Netherlands	363342	104	60	173(152–196)
Belgium	242508	49	32	153 (128–178)
Austria	206236	33	23	143 (117–170)
USA	7824008	2363	1831	129 (127–132)
Hong Kong	175200	18	16	113 (95–130)
Australia	402787	64	70	91 (85–98)
India	388649	48	66	73 (60–85)
Germany	2089845	256	470	54 (48–61)
Nigeria	142920	4	8	50 (1–99)
China	901981	87	188	46 (36–57)
Turkey	191865	8	19	42 (8–76)
Thailand	153909	4	10	40 (-8–88)
Italy	1145370	91	246	37 (27–47
France	1394124	108	305	35 (26–44)
Spain	531289	32	100	32 (16–48)
Russian Federation	447103	21	80	26 (7–45)
Mexico	402109	13	69	19 (-2–40)
Iran	159391	2	12	17 (-35–68)
Saudi Arabia	134825	1	6	17 (-56–90)
Republic of Korea	442543	13	79	16 (-4–37)
Brazil	806972	21	166	13 (-2–27)
Argentina	323548	6	51	12 (-14–38)
Japan	4192669	113	969	12 (6–18)
Taiwan	308000	4	47	9 (-19–36)